ALUR Allurion Technologies Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
ALUR Stock | Fundamental Analysis & Investment Insights
NYSE
Healthcare
Medical Devices
Current Price
Live
$1.34
Analyst Target
$5.25
+291.8%
Upside
52W High
$7.4
52W Low
$1.02
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
92%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of 0/9, indicating severe operational and financial distress. Despite a gross margin of 60.99% and recent earnings surprises, the company is burning cash rapidly, with negative profitability across all key metrics, including a -187.87% profit margin and -362.30% operating margin. Revenue has collapsed by 50.50% year-over-year, and the stock has lost nearly all value over the past three to five years. While analysts have a $5.25 target price, current fundamentals and insider activity suggest extreme risk.
Key Strengths
High gross margin (60.99%) suggests strong pricing power or low production costs in core operations
Recent quarterly earnings have consistently beaten estimates, with an average surprise of +25.09% over the last four quarters
Current ratio of 1.26 indicates some short-term liquidity, albeit minimal
Analyst target price of $5.25 implies ~291% upside from current levels, suggesting potential speculative interest
Operating in the high-growth medical devices sector, which may offer long-term tailwinds
Key Risks
Piotroski F-Score of 0/9 signals extreme financial weakness and high risk of continued deterioration
Negative Price/Book (-0.13) and negative ROA (-71.87%) indicate the company is insolvent on an asset and equity basis
Revenue down 50.50% YoY, reflecting collapsing demand, loss of market share, or operational failure
Forward P/E of -2.79 and lack of Altman Z-Score due to financial instability suggest high bankruptcy risk
Insider selling activity and lack of buy transactions signal lack of confidence from corporate insiders
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ALUR against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning ALUR from our newsroom.
Newest → oldest
No matching news yet.